s and benefits of alternative devices or
procedures. This differs from the judgment about whether a study poses a SR or NSR which
is based solely upon the seriousness of the harm that may result from the use of the
device. Minutes of IRB meetings must document the rationale for SR/NSR and subsequent
approval or disapproval decisions for the clinical investigation. </p>

<p>FDA considers studies of all significant risk devices to present more than minimal
risk; thus, full IRB review for all studies in